Lv41
624 积分 2026-05-15 加入
多囊卵巢综合征合并胰岛素抵抗诊治专家共识
23天前
已完结
Emerging pharmacotherapies for obesity: A systematic review
1个月前
已完结
Association of Glucagon-Like Peptide-1 Receptor Agonists With Menstrual Events in Reproductive-Aged Patients
2个月前
已完结
Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China
2个月前
已完结
Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review
2个月前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
《中国居民营养与慢性病状况报告（2020年）》
3个月前
已完结
中国成人肥胖症防治专家共识
3个月前
已完结
Orforglipron added to titrated insulin glargine in type 2 diabetes: the ACHIEVE-5 randomized clinical trial
3个月前
已完结
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
3个月前
已完结
β-内酰胺抗生素作用机制的研究进展
4个月前
已采纳
皖公网安备34019202002308
